Short answer
West Pharmaceutical Services (WST) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 2026 annual meeting held May 4 with 91.83% shareholder representation, supporting strong voting participation.
West Pharmaceutical Services 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 2026 annual meeting held May 4 with 91.83% shareholder representation, supporting strong voting participation
- All 11 director nominees elected through 2027; Deborah Keller received highest opposition with 5,599,392 votes against
- Executive compensation approved with 60,107,802 votes for, indicating continued shareholder support for pay practices
- PwC appointment ratified for fiscal 2026 despite 7,556,514 votes against
- Independent Board Chair Policy rejected, 34,245,125 votes against versus 29,592,488 for
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other West Pharmaceutical Services 8-K filings
Get the next WST 8-K as it lands
Follow WST for push alerts, or ask the research agent what this filing means.